BEATW
Heartbeam Inc. WarrantKey Statistics
About Heartbeam Inc. Warrant
Heartbeam Inc. Warrant (BEATW) offers a compelling investment opportunity tied to Heartbeam Inc., an innovative healthcare technology company dedicated to revolutionizing cardiac diagnostics through artificial intelligence and digital health solutions. The company's advanced platform enhances diagnostic accuracy for myocardial infarctions, promoting timely medical interventions that can drastically improve patient outcomes. In a landscape where demand for remote monitoring and telehealth services is surging, Heartbeam stands poised to leverage significant market growth, positioning BEATW as a strategic choice for institutional investors seeking exposure to transformative medical technologies with a meaningful impact on patient care.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | -164.20% |
| Return on Assets | -90.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.30 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $5.19M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently contracting